Myeloid Leukaemia After Cancer Treatment
Author Information
Author(s): A. Nandakumar, S. Davis, S. Moolgavkar, R.P. Witherspoon, S.M. Schwartz
Primary Institution: Fred Hutchinson Cancer Research Center
Hypothesis
Does chemotherapy and radiotherapy for a first primary cancer increase the risk of developing second primary myeloid leukaemia?
Conclusion
Chemotherapy, particularly with cyclophosphamide and prednisone, significantly increases the risk of developing second primary myeloid leukaemia, while radiotherapy does not.
Supporting Evidence
- The risk of myeloid leukaemia in patients who received cyclophosphamide was 7.4 times higher.
- Patients receiving prednisone with chemotherapy had a relative risk of 44.4 for developing myeloid leukaemia.
- Radiotherapy did not show an increased risk of myeloid leukaemia.
Takeaway
If someone gets treated for cancer with certain drugs, they might get another type of cancer called myeloid leukaemia later on.
Methodology
A population-based case-control study with 97 cases of myeloid leukaemia and 194 matched controls.
Potential Biases
Potential bias due to reliance on medical records and matching controls.
Limitations
The study may not account for all potential confounding factors and relies on medical records which may have gaps.
Participant Demographics
Patients were residents of 13 counties in western Washington State, aged 22 to 96 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 1.3-43.8
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website